Spire Healthcare Group (LON:SPI) Reaches New 1-Year Low – Here’s Why

Shares of Spire Healthcare Group plc (LON:SPI) reached a new 52-week low on Monday . The company traded as low as GBX 168.20 ($2.18) and last traded at GBX 173.40 ($2.24), with a volume of 1417725 shares changing hands. The stock had previously closed at GBX 177.20 ($2.29).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Spire Healthcare Group from GBX 320 ($4.14) to GBX 300 ($3.88) and set a “buy” rating for the company in a research report on Thursday, March 6th.

Spire Healthcare Group Price Performance

The business has a 50 day simple moving average of GBX 225.22 and a two-hundred day simple moving average of GBX 228.60. The firm has a market capitalization of £707.12 million, a P/E ratio of 25.06, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70.

Spire Healthcare Group (LON:SPI) last announced its earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. On average, sell-side analysts expect that Spire Healthcare Group plc will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.